Organic sales, which exclude exchange rate effects, acquisitions and divestments, increased by 2%

Similar documents
JANUARY 1 DECEMBER 31, 2017

JANUARY 1 SEPTEMBER 30, 2018

I n t e r i m R e p o r t Q

JANUARY 1 MARCH 31, 2018

JANUARY 1 JUNE 30, 2017

Interim Report Jan June, 2017

Interim Report Q1 2013

Interim Report Q3 2017

I n t e r i m R e p o r t Q

Consolidated Statement of Profit or Loss (in million Euro)

Consolidated Statement of Profit or Loss (in million Euro)

POU CHEN CORPORATION AND SUBSIDIARIES

ASSETS 31 March December 2017

I n t e r i m R e p o r t Q

ASSETS 30 June December 2017

Q JANUARY 1 MARCH 31, 2018 (compared with the year-earlier period) EARNINGS TREND

Cash 1,536,955,678 1,938,616,493 1,535,161,842 1,936,147,365

JANUARY 1 SEPTEMBER 30, 2018 (compared with the year-earlier period)

Note of Transition to IFRS

EBITDA margin Earnings per share SEK Operating cash flow ,

I n t e r i m R e p o r t Q

CIMB Thai Bank Public Company Limited Statements of Financial Position As at 31 December 2018

Consolidated Statement of Financial Position

ACER INCORPORATED AND SUBSIDIARIES. Consolidated Balance Sheets

ASSETS 31 December December 2016

BOUYGUES GROUP CONSOLIDATED FINANCIAL STATEMENTS

FAR EASTERN NEW CENTURY CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheet - 1/2

ASSETS 31 December December 2014

EBITDA margin Earnings per share SEK Operating cash flow ,751 2,273

Interim report. 1 January 31 March I n t e r i m r e p o r t Q JANUARY 31 MARCH 2008 (compared with the same period previous year)

Condensed Consolidated Interim Financial Statements as of September 30, 2018

ORIENTAL UNION CHEMICAL CORPORATION AND SUBSIDIARIES

Financial Statements for Fiscal 2003 (April 1, 2003 to March 31, 2004) Nippon Steel Chemical Co., Ltd.

Group statement of comprehensive income (IFRS) Restated

BOUYGUES GROUP CONSOLIDATED FINANCIAL STATEMENTS

ASSETS 30 September December 2017

CONSOLIDATED FINANCIAL STATEMENTS These Consolidated Financial Statements were publicly released in the Japanese language on November 9, 2016.

Consolidated Balance Sheet - 1/2

Consolidated Financial Statements and Primary Notes

Financial Section. 57 Consolidated Balance Sheets. 59 Consolidated Statements of Operations. 60 Consolidated Statements of Comprehensive Income

(Expressed in Thousands of New Taiwan Dollars)

Q1: Strong Sales and solid Cash Flow

Financial Statement Balance Sheet

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)

Financial definitions

CONSOLIDATED BALANCE SHEET

VESTEL ELEKTRONİK SANAYİ VE TİCARET AŞ

2016/2/25 Financial Statement Balance Sheet

FUJI YAKUHIN CO., Ltd. Consolidated Financial Statements For the Year ended March 31,2017

ZORLU ENERJİ ELEKTRİK ÜRETİM A.Ş. CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS AS OF 30 SEPTEMBER 2013 AND 31 DECEMBER 2012

October December Revenue SEK 677 million (664) Earnings after tax SEK -48 million (-18) Earnings per share SEK (-0.12)

CONSOLIDATED BALANCE SHEET

FINANCIAL RESULTS. Consolidated Financial Statements - Fiscal Year Ended March 31, Consolidated Balance Sheets

FINANCIAL RESULTS FOR THE NINE MONTHS ENDED DECEMBER 2017

(Expressed in Thousands of New Taiwan Dollars)

Performance and Information

Consolidated Statement of Profit or Loss (in million Euro)

Accounting Title 2016/3/ /12/ /3/31 Balance Sheet

Gun Ei Chemical Industry Co., Ltd.

Three Months Ended Twelve Months Ended 12/31/ /31/ /31/ /31/

GILAT SATELLITE NETWORKS LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS U.S. dollars in thousands (except share and per share data)

ASPEED TECHNOLOGY INC. AND SUBSIDIARIES

YAŞAR HOLDİNG A.Ş. CONSOLIDATED INTERIM FINANCIAL STATEMENTS AT 30 SEPTEMBER 2018

KEY FIGURES SEKk Q4 Q4 JAN DEC JAN - DEC

Financial Results of the Principal Subsidiaries

Consolidated Statements of Profit or Loss

Consolidated Financial Statements for The 2nd Quarter of FY2018 (April 1, September 30, 2018)

5. Consolidated Financial Statements (1) Consolidated Balance Sheets

Reviewed Reviewed Not Reviewed Not Reviewed. Notes 2018

Interim consolidated statement of financial position as of 30 September 2018 (Amounts expressed in Turkish Lira ( TL ) unless otherwise indicated.

XYZ PLC. Statement of Comprehensive Income (Single statement approach, analyzed by function of expense) For the year ended 31 March 2013

Consolidated Financial Statements for The 2nd Quarter of FY2017 (April 1, September 30, 2017)

Group Consolidated Income Statement

Consolidated Financial Statements and Primary Notes

ASSETS 31 March December 2015

Consolidated Balance Sheets Consolidated Balance Sheet

Year-end Report JANUARY 31 DECEMBER 2009 (compared with corresponding period a year ago) CEO'S COMMENTS EARNINGS TREND

Consolidated Financial Statements for The 3rd Quarter of FY2017 (April 1, December 31, 2017)

Summary of Accounting Report for the Fiscal Year Ended March 2018(IFRS) (April 1, 2017 March 31, 2018)

Overview of consolidated financial statements

Twelve Months Ended December 31 (In thousands, except per share amounts)

Consolidated Balance Sheets

Management s Responsibility

Consolidated Financial Statements for The Year of FY2017 (April 1, March 31, 2018)

Financial Results For the Fiscal Year 2016 ending January 31, 2016

2. Reconciliation between Japanese GAAP and IFRS

Unappropriated retained earnings (accumulated deficit) Total unappropriated retained earnings (accumulated deficit) 676, ,797 Total retained ear

Summary of Consolidated Financial Results for the Fiscal Year Ended March 2015 (unaudited)

DANA HOLDING CORPORATION Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures

Group income statement (IFRS) - Restated (unaudited)

Cash and cash equivalents 2,588,430 2,501,742 1,011,412 1,176,045. Fixed deposits less than one year 37,057 64,803 14,960 34,203

TOTAL CURRENT ASSETS

SEAGATE TECHNOLOGY PLC CONDENSED CONSOLIDATED BALANCE SHEETS

YEAR-END REPORT 2014 Stockholm February 6, 2015

FINANCIAL RESULTS FOR THE YEAR ENDED MARCH 2014

SEAGATE TECHNOLOGY PLC CONDENSED CONSOLIDATED BALANCE SHEETS

April June Net debt SEK 843 million ( December 2013)

ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)

Accounting Title 2015/12/ /12/31 Balance Sheet

Transcription:

E x t e n d e d i n f o r m a t i o n I n t e r i m R e p o r t Q 1 2 0 1 7 C o m b i n e d H y g i e n e and F o r e s t p r o d u c t s b u s i n e s s 1 JANUARY 31 MARCH 2017 (compared with same period a year ago) Net sales totaled SEK 29,104m (27,915) Organic sales, which exclude exchange rate effects, acquisitions and divestments, increased by 2% Operating profit decreased 2% to SEK 2,985m (3,056) Adjusted operating profit, excluding items affecting comparability, rose 5% to SEK 3 404m (3 247) The adjusted operating profit was 11.7% (11.6) Adjusted profit before tax rose 6% to SEK 3,102m (2,922) Items affecting comparability totaled SEK -419m (-191), of which SEK -145m (-185) affects cash flow Profit for the period was SEK 2,019m (2,035) Earnings per share were SEK 2.60 (2.74) The adjusted return on capital employed was 11.8% (11.9%) Cash flow from current operations was SEK 2,331m (1,821) Acquisition of BSN medical has been closed as of April 3, 2017 SCA s Annual General Meeting approved the distribution and listing of the hygiene business the future hygiene and health company Essity AB. The preparations for the distribution and the listing of SCA Hygiene AB are under way, with the first day of separate trading in the two companies scheduled for June 2017. EARNINGS TREND SEKm 1703 1603 % Net sales 29,104 27,915 4 Gross profit 7,638 7,327 4 Adjusted gross profit 1 7,850 7,349 7 Operating profit 2,985 3,056-2 Adjusted operating profit 1 3,404 3,247 5 Financial items -302-325 Profit before tax 2,683 2,731-2 Adjusted Profit before tax 1 3,102 2,922 6 Tax -664-696 Adjusted tax 1-761 -736 Net profit for the period 2,019 2,035-1 Adjusted net profit for the period 1 2,341 2,186 7 Earnings per share, SEK 2.60 2.74 1 Excluding items affecting comparability, for amounts see page 2.

b u s i n e s s 2 STATEMENT OF PROFIT OR LOSS SEKm 2017:1 2016:1 2016:4 1703 1603 Net sales 29,104 27,915 30,568 29,104 27,915 Cost of goods sold 1-21,254-20,566-22,196-21,254-20,566 Items affecting comparability 1,2-212 -22-48 -212-22 Gross profit 7,638 7,327 8,324 7,638 7,327 Sales, general and administration 1-4,475-4,134-4,732-4,475-4,134 Items affecting comparability including impairments 1,2-207 -169-648 -207-169 Share of profits of associates and joint ventures 29 32 45 29 32 Operating profit 2,985 3,056 2,989 2,985 3,056 Financial items -302-325 -289-302 -325 Profit before tax 2,683 2,731 2,700 2,683 2,731 Tax -664-696 -1,117-664 -696 Net profit for the period 2,019 2,035 1,583 2,019 2,035 Earnings attributable to: Owners of the parent 1,823 1,922 1,398 1,823 1,922 Non-controlling interests 196 113 185 196 113 Earnings per share, SEK - owners of the parent total operations - before dilution effects 2.60 2.74 1.99 2.60 2.74 - after dilution effects 2.60 2.74 1.99 2.60 2.74 Calculation of earnings per share 2017:1 2016:1 2016:4 1703 1603 Earnings attributable to owners of the parent 1,823 1,922 1,398 1,823 1,922 Average no. of shares before dilution, millions 702.3 702.3 702.3 702.3 702.3 Average no. of shares after dilution, millions 702.3 702.3 702.3 702.3 702.3 1 Of which, depreciation -1,570-1,504-1,637-1,570-1,504 2 Distribution of items affecting comparability by function Cost of goods sold -212-22 -48-212 -22 Sales, general and administration -119-169 -468-119 -169 Impairment, etc. -88 0-180 -88 0 Total items affecting comparability -419-191 -696-419 -191 Gross margin 26.2 26.2 27.2 26.2 26.2 Operating margin 10.3 10.9 9.8 10.3 10.9 Financial net margin -1.0-1.2-0.9-1.0-1.2 Profit margin 9.3 9.7 8.9 9.3 9.7 Tax -2.3-2.5-3.7-2.3-2.5 Net margin 7.0 7.2 5.2 7.0 7.2 Excluding items affecting comparability: 2017:1 2016:1 2016:4 1703 1603 Gross margin 27.0 26.3 27.4 27.0 26.3 Operating margin 11.7 11.6 12.1 11.7 11.6 Financial net margin -1.0-1.2-0.9-1.0-1.2 Profit margin 10.7 10.4 11.2 10.7 10.4 Tax -2.6-2.6-3.9-2.6-2.6 Net margin 8.1 7.8 7.3 8.1 7.8

b u s i n e s s 3 CONSOLIDATED OPERATIONG CASH FLOW ANALYSIS SEKm 1703 1603 Operating cash surplus 4,719 4,414 Change in working capital -607-721 Current capital expenditures, net -721-738 Restructuring costs, etc. -221-220 Operating cash flow 3,170 2,735 Financial items -302-325 Income taxes paid -628-665 Other 91 76 Cash flow from current operations 2,331 1,821 Acquisitions 0-6,492 Strategic capital expenditures in non-current assets -771-809 Divestments 22 18 Cash flow before dividend 1,582-5,462 Private placement to non-controlling interest 18 0 Dividend -16-13 Net cash flow 1,584-5,475 Net debt at the start of the period -35,361-29,478 Net cash flow 1,584-5,475 Remeasurement to equity 1,081-2,002 Translation differences 10 418 Net debt at the end of the period -32,686-36,537 Debt/equity ratio 0.39 0.48 Debt payment capacity, % 46 48

b u s i n e s s 4 CONSOLIDATED CASH FLOW STATEMENT SEKm 1703 1603 Operating activities Profit before tax 2,683 2,731 Adjustment for non-cash items 1 1,613 1,204 4,296 3,935 Paid tax -628-665 Cash flow from operating activities before changes in working capital 3,668 3,270 Cash flow from changes in working capital Change in inventories -552 214 Change in operating receivables -153 13 Change in operating liabilities 98-948 Cash flow from operating activities 3,061 2,549 Investing activities Acquisitions 0-4,387 Divestments 22 18 Investment in tangible and intangible assets -1,521-1,610 Sale of tangible assets 32 63 Loan granted to external parties -165-167 Cash flow from investing activities -1,632-6,083 Financing activities New issue 18 0 New borrowing 29,977 6,552 Amortization of loans -4,899-3,394 Dividend -16-13 Cash flow from financing activities 25,080 3,145 Cash flow for the period 26,509-389 Cash and cash equivalents at the beginning of the period 4,482 5,042 Translation differences in cash and cash equivalents -1 7 Cash and cash equivalents at the end of the period 30,990 4,660 Cash flow from operating activities per share, SEK 4.34 3.62 Reconciliation with consolidated operating cash flow statement Cash flow for the period 26,509-389 Loans granted to external parties 165 167 New borrowings -29,977-6,552 Net debt in acquired and divested operations 0-2,105 Amortization of borrowing 4,899 3,394 Investment through financial lease -3 0 Accrued interest -9 10 Net cash flow according to consolidated operating cash flow statement 1,584-5,475 1 Depreciation/amortization and impairment of non-current assets 1,756 1,504 Fair-value measurement of forest assets -231-272 Gains/loss on assets sales and swaps of assets 8-26 Unpaid related to efficiency programs -107 0 Gain/loss on divestments -1 0 Payments related to efficiency programs recognized -125-86 Reversal of provision related to antitrust cases -266 0 Provision related to one-time foreign tax on non-curent assets 450 0 Other 129 84 Total 1,613 1,204

b u s i n e s s 5 CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME SEKm 2017:1 2016:1 2016:4 1703 1603 Profit for the period 2,019 2,035 1,583 2,019 2,035 Other comprehensive income for the period Items that may not be reclassified to the income statement Actuarial gains/losses on defined benefit pension plans 1,080-2,000 3,755 1,080-2,000 Income tax attributable to components of other comprehensive income -303 491-851 -303 491 Items that have been or may be reclassified subsequently to the income statement 777-1,509 2,904 777-1,509 Available-for-sale financial assets 1-2 -3 1-2 Cash flow hedges -242 82 292-242 82 Translation differences in foreign operations 444 175 125 444 175 Gains/losses from hedges of net investments in foreign operations -178-464 648-178 -464 Other comprehensive income from associated companies -29-24 18-29 -24 Income tax attributable to components of other comprehensive income 103 93-220 103 93 99-140 860 99-140 Other comprehensive income for the period, net of tax 876-1,649 3,764 876-1,649 Total comprehensive income for the period 2,895 386 5,347 2,895 386 Total comprehensive income attributable to: Owners of the parent 2,721 336 5,096 2,721 336 Non-controlling interests 174 50 251 174 50 CONSOLIDATED STATEMENT OF CHANGES IN EQUITY SEKm 1703 1603 Attributable to owners of the parent Opening balance, January 1 73,142 70,401 Total comprehensive income for the period 2,721 336 Private placement to non-controlling interest 499 0 Private placement to non-controlling interest, dilution -287 0 Remeasurement effect upon acquisition of non-controlling interests -1-1 Closing balance 76,074 70,736 Non-controlling interests Opening balance, January 1 6,377 5,290 Total comprehensive income for the period 174 50 Dividend -16-13 Private placement to non-controlling interest 461 0 Private placement to non-controlling interest, dilution 287 0 Closing balance 7,283 5,327 Total equity, closing balance 83,357 76,063

b u s i n e s s 6 CONSOLIDATED BALANCE SHEET SEKm March 31, 2017 December 31, 2016 Assets Goodwill 19,104 19,257 Other intangible assets 7,933 7,750 Buildings, land, machinery and equipment 63,354 62,184 Biological assets 31,001 30,770 Participation in joint ventures and associates 1,072 1,123 Shares and participation 46 46 Surplus in funded pension plans 1,658 1,186 Non-current financial assets 628 722 Deferred tax assets 1,577 1,465 Other non-current assets 218 242 Total non-current assets 126,591 124,745 Inventories 14,832 14,347 Trade receivables 17,960 17,811 Current tax assets 867 741 Other current receivables 3,109 2,898 Current financial assets 697 568 Non-current assets held for sale 130 156 Cash and cash equivalents 30,990 4,482 Total current assets 68,585 41,003 Total assets 195,176 165,748 Equity Share capital 2,350 2,350 Other capital provided 6,830 6,830 Reserves 551 400 Retained earnings 66,343 63,562 Attributable to owner of the Parent 76,074 73,142 Non-controlling interests 7,283 6,377 Total equity 83,357 79,519 Liabilities Non-current financial liabilities 51,661 31,360 Provisions for pensions 4,919 5,602 Deferred tax liabilities 11,933 11,718 Other non-current provisions 1,189 1,413 Other non-current liabilities 184 181 Total non-current liabilities 69,886 50,274 Current financial liabilities 1 10,079 5,357 Trade payables 15,942 15,750 Current tax liabilities 1,068 935 Current provisions 1,680 1,447 Other current liabilities 13,164 12,466 Total current liabilities 41,933 35,955 Total liabilities 111,819 86,229 Total equity and liabilities 195,176 165,748 1 Committed credit lines amount to SEK19,132m of which unutilized SEK 19,132m.

b u s i n e s s 7 CONSOLIDATED BALANCE SHEET cont. SEKm March 31, 2017 December 31, 2016 Debt/equity ratio 0.39 0.44 Equity/assets ratio 39% 44% Return on capital employed* 9.8% 10.1% Return on equity 7.8% 7.9% Excluding items affecting comparability: Return on capital employed* 12.4% 12.5% Return on equity 10.9% 11.0% *) Rolling twelve months Equity per share, SEK 118 113 Capital employed 116,043 114,880 - of which working capital 6,861 6,883 Provisions for restructuring costs are included in the balance sheet as follows: - Other provisions** 1,189 1,413 - Operating liabilities 666 898 **) of which, provision for tax risks 558 516 Net debt 32,686 35,361 Total Equity 83,357 79,519